EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Improving cancer clinical trial enrollment and patient understanding using TrialTalk, a structured communication method: a pilot randomized controlled trial

Toby C Campbell, Cassandra Gedeon, Bonyan Qudah, Mallory Jasicki, Kristine L Kwekkeboom, Amy Zelenski

Supportive Care in Cancer · 2026-04 · 34 (4)

DOI: 10.1007/s00520-026-10505-4 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Supportive Care in Cancer, online erschienen am 24.03.2026. Verfasst von Toby C Campbell und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, 53705, USA. tcc@medicine.wisc.edu. Hauptthemen laut MEDLINE: Neoplasms, Communication, Patient Selection, Clinical Trials as Topic. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Wisconsin Carbone Cancer Center, Institute for Clinical and Translational Research, University of Wisconsin, Madison.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Structured, easy-to-interpret approaches are needed to facilitate preference-sensitive decision-making about cancer treatments. The TrialTalk method incorporates a verbal component and a pen-and-paper diagram that outlines the diagnosis, prognostic implications, treatment options, potential outcomes, and anticipated impacts on daily life. This pilot study examined (1) oncologists’ ability to learn and then implement the tool in their clinical practice and (2) the effect of the TrialTalk method on clinical trial consent and enrollment.

Methods

Twenty-seven oncologists from a single academic institution were randomly assigned to the intervention group ( n = 14) or the control group ( n = 13). Intervention group oncologists completed a single, 2-hour TrialTalk training program including a didactic, simulated session with patient actors and feedback from the trainer. Additional feedback and question/answer sessions were available. Oncologists in the control group did not receive TrialTalk training. Clinical trial decisions were collected from patients seen by oncologists in both groups.

Results

Intervention oncologists demonstrated fidelity with the tool after training. Patients of oncologists in the intervention group were significantly more likely to consent to participate in clinical trials than patients of oncologists in the control group (92.9% vs. 82.4%, p = 0.04). Actual enrollment rates after signing consent were equal in both groups (78.2% in the intervention group vs. 73.3% in the control group).

Conclusion

Patients who met with TrialTalk-trained oncologists were more likely to sign consent to participate in a clinical trial. The decision-making conversation with the oncologist is a critical moment for patients considering clinical trial participation, and targeting these encounters has the potential to increase overall trial participation rates.

Trial registration

ClinicalTrials.gov ID: NCT03656276.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsCommunicationPatient SelectionClinical Trials as TopicHumansPilot ProjectsMaleFemaleMiddle AgedDecision MakingAdultPhysician-Patient RelationsComprehensionAgedOncologistsInformed ConsentPatient Participation

Stichwörter der Autor:innen

Clinical trialsDecision toolsDecision-makingPatient–provider communicationTrialTalk

Autor:innen und Institutionen

  • School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, 53705, USA. tcc@medicine.wisc.edu.
  • LAPSCO UMR6024, University Clermont Auvergne, Clermont-Ferrand, France.
  • School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, 53705, USA.
  • School of Nursing, University of Wisconsin-Madison, Madison, WI, 53705, USA.

Förderung

  • University of Wisconsin Carbone Cancer Center
  • Institute for Clinical and Translational Research, University of Wisconsin, Madison

Zitieren

APA

Campbell, T. C., Gedeon, C., Qudah, B., Jasicki, M., Kwekkeboom, K. L., & Zelenski, A. (2026). Improving cancer clinical trial enrollment and patient understanding using TrialTalk, a structured communication method: a pilot randomized controlled trial. Supportive Care in Cancer, 34(4). https://doi.org/10.1007/s00520-026-10505-4

Vancouver

Campbell TC, Gedeon C, Qudah B, Jasicki M, Kwekkeboom KL, Zelenski A. Improving cancer clinical trial enrollment and patient understanding using TrialTalk, a structured communication method: a pilot randomized controlled trial. Supportive Care in Cancer. 2026;34(4). doi:10.1007/s00520-026-10505-4

BibTeX
@article{Campbell2026,
  author = {Campbell, Toby C and Gedeon, Cassandra and Qudah, Bonyan and Jasicki, Mallory and Kwekkeboom, Kristine L and Zelenski, Amy},
  title = {Improving cancer clinical trial enrollment and patient understanding using TrialTalk, a structured communication method: a pilot randomized controlled trial},
  journal = {Supportive Care in Cancer},
  year = {2026},
  volume = {34},
  number = {4},
  doi = {10.1007/s00520-026-10505-4}
}
Kostenlos starten →